Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used. - Wikidata - wikimedia - TriplyDB

Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used.

Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used.

http://www.wikidata.org/entity/Q37000172

about

Role of cues and contexts on drug-seeking behaviour Nicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research.Stimulation of nicotine reward and central cholinergic activity in Sprague-Dawley rats exposed perinatally to a fat-rich diet.New directions in nicotine vaccine design and use.Administration of the nicotinic acetylcholine receptor agonists ABT-089 and ABT-107 attenuates the reinstatement of nicotine-seeking behavior in rats.Effects of varenicline and cognitive bias modification on neural response to smoking-related cues: study protocol for a randomized controlled study Protection genes in nucleus accumbens shell affect vulnerability to nicotine self-administration across isogenic strains of adolescent rat Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal.Bupropion-varenicline interactions and nicotine self-administration behavior in rats.AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology l-tetrahydropalmatine reduces nicotine self-administration and reinstatement in rats.Effects of varenicline on operant self-administration of alcohol and/or nicotine in a rat model of co-abuse.Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers.The effects of varenicline on methamphetamine self-administration and drug-primed reinstatement in female rats.Nicotinic regulation of energy homeostasis.Varenicline-Induced Elevation of Dopamine in Smokers: A Preliminary [(11)C]-(+)-PHNO PET Study.Sex differences in attenuation of nicotine reinstatement after individual and combined treatments of progesterone and varenicline Biomarkers for smoking cessation Rats are the smart choice: Rationale for a renewed focus on rats in behavioral genetics.Peroxisome proliferator-activated receptor (PPAR) agonists as promising new medications for drug addiction: preclinical evidence.Effects of blockade of α4β2 and α7 nicotinic acetylcholine receptors on cue-induced reinstatement of nicotine-seeking behaviour in rats.Effects of chronic varenicline treatment on nicotine, cocaine, and concurrent nicotine+cocaine self-administration.Discriminative Stimulus Properties of S(-)-Nicotine: "A Drug for All Seasons".Varenicline Reduces Context-Induced Relapse to Alcohol-Seeking through Actions in the Nucleus Accumbens.Electrical stimulation of the insular region attenuates nicotine-taking and nicotine-seeking behaviors.Use of varenicline for more than 12 months for smoking cessation in heavy chronic obstructive pulmonary disease smokers unmotivated to quit: a pilot study.Extended nicotine self-administration increases sensitivity to nicotine, motivation to seek nicotine and the reinforcing properties of nicotine-paired cues.The effects of varenicline on methamphetamine self-administration and drug-primed reinstatement in male rats.

P2860

Q26825476-280212C5-A38C-417D-9C90-2B15B93215E5 Q30244252-C3C339EF-50BD-4325-B1EE-963D97076863 Q33552906-BC45E468-A7EC-4E97-ADB6-86328C997C77 Q33719424-7394B351-AC3C-4501-B8C8-DCC097F4501D Q34266602-F0B46741-9AB4-442B-8F4F-5D4DCE25EA29 Q34340037-7696C9BD-D3B4-4743-BDA6-BCD6BBD97560 Q34400233-312C524F-94E9-4E5A-B1DB-F9D0D352E9A2 Q34870758-41F5990E-E0E1-4E19-83CD-EC5869A079E0 Q35091751-D1DFB519-82A7-4574-8424-5DD1C7E9AA82 Q35223957-20556CE7-D26D-428F-AF74-8BC8BB10B444 Q36183737-7229FFA1-4E84-457D-82F1-F757E0E5C593 Q36319552-843DBCD8-BA29-4014-800C-F882D58E26B9 Q36479392-A4BF4F7A-58F1-40B4-A49E-4DB5E10FDC15 Q36494806-5CAD4EAE-BAF1-4733-A124-359C11AEAC99 Q36727840-7DF49906-FA1E-418C-B07B-F652046C11DC Q36798993-6B93E5E5-587D-40D3-9595-519663699767 Q36927551-D61BC19E-9853-4FC8-B689-4497F42CCE6B Q37169216-83A8F13E-41C3-4CE0-993D-EA89C6E78FC8 Q37296970-86B9A049-8772-4A4A-81BC-6D14A31D5D7F Q37304747-AEDD968B-CBDC-4E75-A055-BAB892245CCC Q37351302-C8C4D5F8-9F11-4467-97EC-1522E6F680AB Q37642452-657002C6-532D-4246-87AB-9D1B14004065 Q38732951-509D37A9-6CAE-4245-8A75-433D17DC6ADC Q39196596-41C74A34-DF00-4415-9F06-C546541AB1B1 Q43247605-B54295F2-0122-4AA3-807C-6BFAF944A7A4 Q47417038-A0998300-7BB7-4A36-8214-8A40DBACC142 Q47591687-B0E24A07-4B3E-435D-9A80-9036765ECD2D Q48400058-80813395-7159-4730-9A59-9FE298FE8DAA

P2860

Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used.

http://www.wikidata.org/entity/Q37000172

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 23 September 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Varenicline decreases nicotine ...... ong pretreatment time is used.

@en

Varenicline decreases nicotine ...... ong pretreatment time is used.

@nl

type

label

Varenicline decreases nicotine ...... ong pretreatment time is used.

@en

Varenicline decreases nicotine ...... ong pretreatment time is used.

@nl

prefLabel

Varenicline decreases nicotine ...... ong pretreatment time is used.

@en

Varenicline decreases nicotine ...... ong pretreatment time is used.

@nl

P1433

Q37000172-53B8D6FC-610F-4FA6-B8FB-F392EEAEBC68

P1476

Q37000172-EC8CCBED-488E-46AD-8BE3-59B1E994CCE6

P2093

Q37000172-52BDFDD0-13B3-4DC8-85C3-F177CEE1482A

Q37000172-61B23BDC-4F53-40BB-BF28-62735C5AC428

Q37000172-6E7BE02F-1491-4504-9755-7CF1411B4480

Q37000172-89EB3697-FC30-46EA-A96C-FC6ABC39E019

Q37000172-B8BAE860-F275-4EB6-8B4F-3A4A92F7C079

Q37000172-CD28840B-C57B-4155-9A15-082F679157AE

Q37000172-D583BD3A-FF56-4DB2-BD58-6055C5EE3165

Q37000172-E6D35007-194D-42E9-9AD6-AB6C33830183

Q37000172-F2A7463C-8147-4042-83BA-7057E54FF613

P2860

Q37000172-0A66F155-2087-4619-9853-DB4D508F38FF

Q37000172-1721122E-2E80-44B9-8EE6-FB04DD6E318B

Q37000172-196781E4-1EC2-4BF6-89CF-E7DC0E6989A8

Q37000172-331896AD-6529-4A98-8436-A4B0F7A226E8

Q37000172-47D44F3E-1B2E-42B0-A8F6-15C3CB18D2B5

Q37000172-4DF450ED-F70C-4C2D-BEF3-5F62B4AB327F

Q37000172-53E049FE-CF56-45B6-A1CD-9927203653FA

Q37000172-5FEE6E86-74A7-4398-A64A-F5AEDB4B0075

Q37000172-69ECEC71-23F7-43E8-83AC-6D01FF058CC8

Q37000172-6A3C3F98-068B-4E4A-B692-94F1CDBACA7C

P304

Q37000172-BD15EFE4-B6CC-4788-9D9D-A5390DABD105

P31

Q37000172-54DE2897-7064-43E7-B72E-F7BB23BDC36A

P356

Q37000172-A0184538-EB6B-4F15-B272-37B1E87A74A9

P433

Q37000172-561C73BE-5F51-42BF-A9D5-99A8F6F63EE7

P478

Q37000172-D03023F6-E2DE-4BAF-B3AD-5071615D3E74

P577

Q37000172-07DD4063-09BE-4AE7-AB65-E33AEF446542

P698

Q37000172-962E6F10-697F-41E9-BCA2-524F499BFC88

P932

Q37000172-B584E326-85D4-4930-8770-EC4EBA5C5CFC

P356

S1461145711001398

P1433

The International Journal of Neuropsychopharmacology

P1476

Varenicline decreases nicotine ...... ong pretreatment time is used.

@en

P2093

Abhiram Pushparaj

http://www.w3.org/2001/XMLSchema#string

Bernard Le Foll

http://www.w3.org/2001/XMLSchema#string

Chanel Barnes

http://www.w3.org/2001/XMLSchema#string

Islam Gamaleddin

http://www.w3.org/2001/XMLSchema#string

Maram Khaled

http://www.w3.org/2001/XMLSchema#string

Munmun Chakraborty-Chatterjee

http://www.w3.org/2001/XMLSchema#string

Shaul Lev-Ran

http://www.w3.org/2001/XMLSchema#string

Steven R Goldberg

http://www.w3.org/2001/XMLSchema#string

Yijin Yan

http://www.w3.org/2001/XMLSchema#string

P2860

Nicotine receptor partial agonists for smoking cessation

Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration.

Noradrenergic alpha1 receptors as a novel target for the treatment of nicotine addiction.

Treatment of tobacco dependence: integrating recent progress into practice.

Self-administration of stimulants and serotonergic systems.

Translational research in medication development for nicotine dependence.

Effects of varenicline on smoking cue–triggered neural and craving responses.

Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats.

Effects of chronic caffeine exposure on adenosinergic modulation of the discriminative-stimulus effects of nicotine, methamphetamine, and cocaine in rats.

P304

1265-1274

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S1461145711001398

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21939589

http://www.w3.org/2001/XMLSchema#string

P932

3707493

http://www.w3.org/2001/XMLSchema#string